| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1K | — | — |
| R&D Expense | $1.8M | +20.2% | -12.2% |
| SG&A Expense | $1.6M | -26.1% | -4.5% |
| Operating Income | -$3.4M | +7.3% | +8.7% |
| Net Income | -$4.4M | -27.1% | -32.3% |
| EPS (Basic) | -$0.11 | -10.0% | +15.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.5M | -49.1% | -68.9% |
| Short-term Investments | $17.8M | — | — |
| Current Assets | $21.9M | +184.9% | +79.8% |
| Total Assets | $30.7M | +86.1% | +46.3% |
| Current Liabilities | $3.2M | +22.1% | +16.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.9M | — | — |
| Investing Cash Flow | -$17.8M | — | — |
| Financing Cash Flow | $21.3M | — | — |
| $11.6M |
| +17.0% |
| +1.7% |
| Stockholders' Equity | $19.2M | +189.4% | +98.9% |